Guss J

New York University Grossman School of Medicine, New York.

8 papers

ArticleMDMA

Psychodynamic Perspectives on Psychedelic States and Treatment Contexts: A Conceptual and Clinical Introduction.

Modlin NL, Elek Z, Maggio C +5

Europe PMC2026
ArticleMDMA

A model training curriculum for psychedelic, psycholytic, and entactogen-assisted psychotherapy.

Passie T, Loizaga-Velder A, Danforth A +19

Europe PMC2026
ArticlePsilocybin

Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: an open-label pilot clinical trial.

Aday JS, McAfee J, Conroy DA +16

Europe PMC2025
ArticlePsilocybin

Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use.

Brett J, Knock E, Watson K +3

Europe PMC2024
ArticlePsilocybin

Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial.

Sloshower J, Zeifman RJ, Guss J +5

Europe PMC2024
ArticlePsilocybin

Lower-dose psycholytic therapy - A neglected approach.

Passie T, Guss J, Krähenmann R

Europe PMC2022
ArticlePsilocybin

Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.

Rosa WE, Sager Z, Miller M +19

Europe PMC2022
ArticlePsilocybin

Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer.

Ross S, Agin-Liebes G, Lo S +8

Europe PMC2021